Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01142557
Recruitment Status : Completed
First Posted : June 11, 2010
Last Update Posted : July 11, 2014
Sponsor:
Collaborator:
Gesellschaft für Therapieforschung mbH
Information provided by:
Merck KGaA, Darmstadt, Germany

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2005
Actual Study Completion Date : November 2005